Skip navigation
Pharma Forum 2019 promo banner
15th Life Sciences Accounting & Reporting Congress promo banner
20th Annual Patient Assistance and Access Programs – PAP 2019 promo banner
Hub and SPP Model Optimization promo banner
IISR 2019 — 7th Annual Investigator Initiated Sponsored Research Summit promo banner

FC16120

This compendium consists of materials submitted by the speakers that complement their presentations. We understand what an important resource this material is and we have made a concerted effort to secure biographical sketches, outlines and related materials.

Additionally, you will find included helpful information on solution providers, publications and associations, including links to their websites.

Thank you for your patronage.

Presentations

Workshop A:
Analyze Key Concepts for Specialty Pipeline Management

I. Impacts of PCSK9 Drugs

II. Biosimilars Updates

III. Recently Approved Specialty Therapies

IV. Optimize Specialty Benefit Design

Bonus Material 1 | Bonus Material 2 | Bonus Material 3

Workshop Leaders:

Sheila Arquette
Director of Pharmacy
Independent Health

Matthew Gibbs, Pharm.D.
President, Commercial & Managed Markets
EnvisionRx

Peter Dehnel
Medical Director
Blue Cross and Blue Shield of Minnesota

Workshop B:
Delve into Medication Therapy Management and Outcomes

I. Case Studies — Cost Savings and Quality Results from Successful MTM programs

II. Explore the Evolving Role of the Pharmacist

III. Achieve and Maintain Optimal Star Ratings and Performance Measures

Workshop Leaders:

Hasim Zaibak
President
Hayat Pharmacy

Megan Jolley Milne, Pharm.D., BCACP
Pharmacist
Medical Review Institute of America

Anticipate the Market Place Changes that Will Impact Specialty Product Management

Steven R. Peskin, M.D., MBA, FACP
Senior Medical Director, Horizon Blue Cross Blue Shield New Jersey;
Associate Clinical Professor of Medicine, Rutgers RWJ Medical School

CASE STUDY Value-Based Reimbursement Programs for Specialty Products

Barbara Haasis, R.N., CCRN
Senior Clinical Lead, Value Based Payment Programs
Florida Blue

Patient Support Services for Limited Distribution Drugs

Mike Ellis
Corporate Vice President, Specialty Pharmacy
Walgreens

Distribution of Specialty Therapies by Various Methods

Michael Jacobs, R.Ph.
Senior Director, Health and Wellness
Walmart

MULTI-STAKEHOLDER PANEL DISCUSSION Overcome Challenges in Managing the High Costs of Specialty Therapies

Moderator:

Peter Dehnel
Medical Director
Blue Cross and Blue Shield of Minnesota

Panelists:

Sheila Arquette
Director of Pharmacy
Independent Health

Neil Shah
Clinical Pharmacist, Specialty Pharmacy
Blue Cross and Blue Shield of North Carolina

Rebecca Shanahan
Chief Executive Officer
Avella Specialty Pharmacy

Learn Best Practices for Specialty Therapy Usage Management

Neil Shah
Clinical Pharmacist, Specialty Pharmacy
Blue Cross and Blue Shield of North Carolina

CASE STUDY Washington Update on Medicaid and Medicare Regarding Specialty Therapies

Roxanne Newland
Senior Consultant
Gorman Health Group

CASE STUDY Balancing Access to Specialty Pharmacy and Cost Containment in a Regulated Market — Massachusetts Case Study

Michael Katzman
Director, Public Government and Regulatory Affairs
Blue Cross Blue Shield of Massachusetts

Effectively Manage Costs of Specialty Therapies through Biosimilars

Joseph Fuhr
Professor of Economics
Widener University

Ensure Access and Gain Value from Oral Oncolytics

Thomas Harwood
Director of Finance
NSHOA Cancer Centers in NY

Speaker Bios

Sheila Arquette
Director of Pharmacy
Independent Health

Peter Dehnel
Medical Director
Blue Cross and Blue Shield of Minnesota

Mike Ellis
Corporate Vice President, Specialty Pharmacy
Walgreens

Joseph Fuhr
Professor of Economics
Widener University

Matthew Gibbs, Pharm.D.
President, Commercial & Managed Markets
EnvisionRx

Barbara Haasis, R.N., CCRN
Senior Clinical Lead, Value Based Payment Programs
Florida Blue

Thomas Harwood
Director of Finance
NSHOA Cancer Centers in NY

Michael Jacobs, R.Ph.
Senior Director, Health and Wellness
Walmart

Michael Katzman
Director, Public Government and Regulatory Affairs
Blue Cross Blue Shield of Massachusetts

Megan Jolley Milne, Pharm.D., BCACP
Pharmacist
Medical Review Institute of America

Roxanne Newland
Senior Consultant
Gorman Health Group

Steven R. Peskin, M.D., MBA, FACP
Senior Medical Director, Horizon Blue Cross Blue Shield New Jersey;
Associate Clinical Professor of Medicine, Rutgers RWJ Medical School

Neil Shah
Clinical Pharmacist, Specialty Pharmacy
Blue Cross and Blue Shield of North Carolina

Rebecca Shanahan
Chief Executive Officer
Avella Specialty Pharmacy

Hasim Zaibak
President
Hayat Pharmacy

  Agenda
Click here to view

SPONSORS

The Burchfield Group

Next IT

 

Next IT Healthcare is the leader in patient engagement—driving behavior change and improving outcomes.

US Bioservices

Upcoming Events

Reimbursement and Contracting
February 4-5, 2016 • Philadelphia, PA

Hub and SPP Model Optimization
February 23-24, 2016 • Philadelphia, PA

PAP 2016 – 17th Patient Assistance and Access Programs
March 8-9, 2016 • Baltimore, MD

Bio/Pharmaceutical Pricing and Contracting
March 15-16, 2016 • Washington, DC

e-Rx and EHR
March 21-22, 2016 • Philadelphia, PA

Oncology Commercialization & Market Access
March 22-23, 2016 • San Francisco, CA

PBM Formulary Exclusions Summit
March 30-31, 2016 • Las Vegas, NV

Formulary, Co-Pay and Access Summit
April 5-6, 2016 • Philadelphia, PA

Electronic Benefit Verification & Information Exchange Summit
May 17-18, 2016 • Philadelphia, PA

Pharmacy Channel Strategies for Specialty Products
June 8-9, 2016 • Philadelphia, PA

Reimbursement and Access 2016
August 17-18, 2016 • Philadelphia, PA

Specialty Therapies 2017
January 26-27, 2017 • Las Vegas, NV